BJH - volume 5, issue 3, september 2014
P. Mineur MD, F. Hubert , E. Van den Neste MD, PhD, K. Peeters PhD
We observed severe hyponatremia in a patient who was treated with bortezomib for multiple myeloma. The patient was diagnosed with the syndrome of inappropriate secretion of antidiuretic hormone due to bortezomib.
Top
